Inventor
Milan S. Blake
Inventor
Fulton, MD, US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides27%
A61KPreparations for medical, dental or toiletry purposes21%
C12NMicroorganisms or enzymes15%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
Y02ATechnologies for adaptation to climate change3%
C08BPolysaccharides1%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
PatentTitleYear
8,247,225'DNA promoters and anthrax vaccines'20127,829,321'Method for the production of bacterial toxins'20107,790,185'Method for the production of bacterial toxins'20107,758,855'DNA promoters and anthrax vaccines'20107,332,173'Group A streptococcal polysaccharide immunogenic compositions and methods'20087,045,314'Method for the production of bacterial toxins'20067,018,813'Method for the production of bacterial toxins'20066,686,180'Method for the production of bacterial toxins'20046,664,094'Neisserial vaccine free of immunologically functional PIII or class 4 proteins'20036,613,336'Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide'20036,451,317'Immunogenic conjugates comprising a Group B meningococcal porin and an H influenzae polysaccharide'20026,280,738'Non-IgA Fc binding forms of the group B streptococcal .beta. antigens'20016,248,570'Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines'20016,153,406'Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B'20006,132,959'Method for early detection of HIV infection in babies'20006,124,132'Use of anti-HIV IGA antibodies for producing immunological protection against the human immunodeficiency virus'20006,013,267'Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis'20005,879,686'Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis'19995,869,047'Methods for therapeutically treating immunocomprised persons'19995,866,135'Group A streptococcal polysaccharide immunogenic compositions and methods'19995,747,287'Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis'19985,439,808'Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis'19955,202,232'IgA binding protein'19934,795,702'Diagnostic method for gonorrhea by assay of IgA1 fragments'19894,757,134'IgA binding protein'1988Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1988–2008Patents assigned to UNIV ROCKEFELLER (9)· patent assignee history
1988–2008Based in New York, NY, US· patent location history
1995–2000Patents assigned to NORTH AMERICAN VACCINE INC (6)· patent assignee history
1999–2000Patents assigned to BLAKE LAB INC (3)· patent assignee history
1999Based in Silver Spring, MD, US· patent location history
2000–2012Based in Fulton, MD, US· patent location history
2001–2010Patents assigned to BAXTER INT (8)· patent assignee history
2004–2010Patents assigned to BAXTER HEALTHCARE SA (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV ROCKEFELLER | 9 | 1988–2008 |
| BAXTER INT | 8 | 2001–2010 |
| NORTH AMERICAN VACCINE INC | 6 | 1995–2000 |
| BAXTER HEALTHCARE SA | 4 | 2004–2010 |
| BLAKE LAB INC | 3 | 1999–2000 |
Locations
| Location | Patents | Span |
|---|---|---|
| Fulton, Maryland, US | 12 | 2000–2012 |
| New York, New York, US | 12 | 1988–2008 |
| Silver Spring, Maryland, US | 1 | 1999 |